Single-agent interleukin-2 in the treatment of metastatic melanoma

QUESTIONS: What is the role of single-agent interleukin-2 (il-2) in the treatment of adults with metastatic melanoma? If there is a role for single-agent il-2, what patient population can appropriately be considered for treatment? If there is a role for single-agent il-2, what dose and schedule are...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrella, T., Quirt, I., Verma, S., Haynes, A.E., Charette, M., Bak, K.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2007
Materias:
Practice Guideline Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891192/
https://www.ncbi.nlm.nih.gov/pubmed/17576460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891192/
https://www.ncbi.nlm.nih.gov/pubmed/17576460

Ejemplares similares